1. In vitro antileukemic activity of novel adenosine derivatives bearing boron cluster modification.
- Author
-
Żołnierczyk, Jolanta D., Olejniczak, Agnieszka B., Mieczkowski, Adam, Błoński, Jerzy Z., Kiliańska, Zofia M., Robak, Tadeusz, and Leśnikowski, Zbigniew J.
- Subjects
- *
ADENOSINE derivatives , *BORON , *LEUKEMIA treatment , *CELL-mediated cytotoxicity , *PROTEOLYSIS , *APOPTOSIS - Abstract
A series of adenosine derivatives bearing a boron cluster were synthesized and evaluated for their cytotoxicity against primary peripheral mononuclear cells from the blood of 17 patients with leukemias (16 CLL and 1 very rare PLL), as well as from 5 healthy donors used as a control. Among the tested agents, two, i.e., compounds 1 and 2 , displayed high in vitro cytotoxicity and proapoptotic potential on leukemic cells, with only scarce activity being seen against control cells. Biological tests related to apoptosis revealed the activation of the main execution apoptotic enzyme, procaspase-3, in CLL and PLL cells exposed to compounds 1 and 2 . Moreover, the above compounds indicated high activity in the proteolysis of the apoptotic markers PARP-1 and lamin B1, fragmentation of DNA, and the induction of some changes in the expression of the Mcl-1, protein apoptosis regulator in comparison with control cells. [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF